Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group considers how the standard of healthcare for patients with diabetes is impacted by COVID-19.
Though heart damage plays a role in how someone deals with COVID-19, researchers at the American Heart Association found that blood pressure medicines don't impact your chances.
Stephen Jones, CEO and Co-Founder at Nourish Fit Food, discusses how Britain's obesity plan will continue to fail unless the concept of health itself is radically redefined.
Barak Katz, General Manager at Essence Smartcare, reveals how the information we currently aren’t collecting could revolutionise the effect falls have on the victims and their care networks.
With only 2 months to go, Nicholas Kelly, CEO, Axela Ltd, discusses what needs to be done now in order to prepare healthcare services for the post-Brexit era.
The NHS has announced that applications for the second round of the AI in Health and Care Award are now open.
In the first pilot of whole city testing, residents and workers in Liverpool will be offered COVID-19 testing, whether they have symptoms or not.
Findings from a new study have cites that hospital floors are a hotspot for bacteria to breed, creating a route of transfer to patients.
A cardiologist from the University of Cincinnati is partnering with researchers in St. Louis and rural Georgia to develop a smartphone app that will deliver COVID-19 information and education to Black communities.
US health insurance coverage decreased significantly, resulting in 25,180 excess deaths before COVID - researchers say this number will triple if the Affordable Care Act is overturned.
The European Commission is launching an additional set of actions to help limit the spread of the coronavirus and save lives.
Researchers from the Health Economics Unit and University of Leeds looked at the cost of treating strokes and found that the drugs prescribed are so effective they save the NHS money.
A new study in the US shows that people with disabilities view healthcare as a human right and believe that this perspective does translate to policy-makers.
While AstraZeneca and Oxford University continue to work on a UK COVID-19 vaccine, what about the rest of the world?
A new study, led by researchers at Queen Mary University of London, uses novel biomarkers to predict patient responsiveness to rheumatoid arthritis treatment.
The largest at-home antibody study for COVID-19 has found that the number of people with antibodies fell by 26.5% after infection.
Boston Medical Center researchers found that Black individuals, above all other racial groups, are less likely to receive lung cancer chemotherapy.
Researchers at NYU School of Global Public Health and NYU Grossman School of Medicine have warned against the dangers of child influences promoting unhealthy food and drinks on their YouTube channels.
A new study found that it costs patients over $450 a year when they are prescribed the wrong drugs, making them twice as likely to go to hospital.
Dr Owain Rhys Hughes, founder and CEO of Cinapsis, explores how remote GP consultations are providing opportunities for both patients and the NHS.